InsiderClue
← All stocks

OCULAR THERAPEUTIX, INC

OCUL Net buying
CIK 0001393434 #1892 in the set updated 17 Sep 2026
Bought (120 mo)
$26.37M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$5.82M
$4.68M on a plan · $0.00 straight out of an exercise
Sold at will
$1.14M
24 of 71 sales
Net
+$20.55M
+$25.24M against sales at will

By person

28 insiders · 140 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
SUMMER ROAD LLC entity
10% owner
$23.35M (34)
—
+$23.35M
14,210,262
6.47%
$145.51M
+50.8%
Dugel Pravin
See Remarks
—
$3.00M (11) scheduled
−$3.00M
3,270,332
1.49%
$33.49M
—
Sawhney Amarpreet
Chairman of the Board
$950.29K (6)
—
+$950.29K
1,245,424
0.5671%
$12.75M
+51.6%
LINDSTROM RICHARD L MD
Director
$775.34K (3)
$143.00K (1)
+$632.34K
260,933
0.1188%
$2.67M
+499.0%
Notman Donald
Chief Operating Officer
$108.65K (3)
$455.10K (10)
−$346.45K
366,529
0.1669%
$3.75M
+1,930%
Waheed Nadia
Chief Medical Officer
—
$332.46K (4) scheduled
−$332.46K
300,079
0.1366%
$3.07M
—
Kaiser Peter
Chief Development Officer
—
$327.25K (9) scheduled
−$327.25K
264,378
0.1204%
$2.71M
+122.9%
Saroj Namrata
Chief Business Officer
—
$277.79K (1) scheduled
−$277.79K
254,620
0.1159%
$2.61M
+26.4%
Nayak Sanjay
Chief Strategy Officer
—
$261.55K (11) scheduled
−$261.55K
326,898
0.1488%
$3.35M
+226.9%
Mattessich Antony C.
President and CEO
$500.99K (6)
$269.63K (3)
+$231.36K
595,201
0.2710%
$6.09M
—
Heier Jeffrey S.
Chief Scientific Officer
$145.35K (2)
$349.48K (9) scheduled
−$204.13K
318,326
0.1449%
$3.26M
+177.5%
Bollag Daniel M
Sr. VP Reg. Affairs & Quality
$197.30K (2)
—
+$197.30K
42,100
0.0192%
$431.10K
—
Opaleye Management Inc. entity
Previously a 10% owner
$137.92K (3)
—
+$137.92K
5,122,500
2.33%
$52.45M
+0.7%
Anderman Todd
Chief Legal Officer
—
$137.37K (1) scheduled
−$137.37K
152,468
0.0694%
$1.56M
—
Hanley Kevin F.
Sr. VP Technical Operations
$111.00K (2)
—
+$111.00K
20,000
0.0091%
$204.80K
—
Ozden Rabia Gurses
Chief Medical Officer
—
$100.58K (4)
−$100.58K
153,054
0.0697%
$1.57M
+365.7%
Strassburger Philip C.
General Counsel
—
$89.32K (3)
−$89.32K
161,493
0.0735%
$1.65M
+3,399%
White Christopher G
Chief Business Officer
—
$78.92K (3)
−$78.92K
123,689
0.0563%
$1.27M
—
Goldstein Michael H.
President, Ophthalmology & CMO
$71.62K (2)
—
+$71.62K
313,335
0.1427%
$3.21M
+37.4%
Williams Leslie J.
Director
$19.80K (1)
—
+$19.80K
65,433
0.0298%
$670.03K
—
PEACOCK BRUCE
Director
—
— (1)
$0.00
0
0.0000%
$0.00
—
Meyers Steve Lawrence
Chief Commercial Officer
—
—
—
217,628
0.0991%
$2.23M
+42.5%
Robinson David Wayne
Global CCO
—
—
—
136,000
0.0619%
$1.39M
—
Warden Charles M
Director
—
—
—
100,464
0.0457%
$1.03M
−95.5%
Robins Jason Shand
Chief Financial Officer
—
—
—
68,097
0.0310%
$697.31K
+29.3%
Graves Adrienne L
Director
—
—
—
64,000
0.0291%
$655.36K
—
RAINES MERILEE
Director
—
—
—
60,933
0.0277%
$623.95K
—
Hong Seung Suh
Director
—
—
—
60,933
0.0277%
$623.95K
—

Individual transactions

24
Insider
Date
Role
Action
Shares
Price
Amount
Notman Donald
31 Aug 2026
Chief Operating Officer
Sell
1,099
$10.24
$11.25K
Notman Donald
12 Feb 2026
Chief Operating Officer
Sell
11,446
$9.04
$103.47K
Notman Donald
4 Feb 2026
Chief Operating Officer
Sell
6,035
$8.54
$51.54K
Notman Donald
2 Feb 2026
Chief Operating Officer
Sell
5,455
$9.14
$49.86K
Notman Donald
2 Sep 2025
See Remarks
Sell
1,066
$12.43
$13.25K
Notman Donald
4 Feb 2025
See Remarks
Sell
11,119
$7.81
$86.84K
Notman Donald
31 Jan 2025
See Remarks
Sell
6,301
$7.84
$49.40K
Mattessich Antony C.
5 Feb 2024
President and CEO
Sell
19,642
$4.86
$95.46K
Notman Donald
5 Feb 2024
Chief Financial Officer
Sell
6,212
$4.86
$30.19K
Ozden Rabia Gurses
5 Feb 2024
Chief Medical Officer
Sell
6,346
$4.86
$30.84K
Strassburger Philip C.
5 Feb 2024
General Counsel
Sell
6,029
$4.86
$29.30K
White Christopher G
5 Feb 2024
Chief Business Officer
Sell
5,910
$4.86
$28.72K
Mattessich Antony C.
31 Jan 2024
President and CEO
Sell
18,338
$4.95
$90.77K
White Christopher G
31 Jan 2024
Chief Business Officer
Sell
5,147
$4.95
$25.48K
Strassburger Philip C.
31 Jan 2024
General Counsel
Sell
6,831
$4.95
$33.81K
Ozden Rabia Gurses
31 Jan 2024
Chief Medical Officer
Sell
7,764
$4.95
$38.43K
Notman Donald
31 Jan 2024
Chief Financial Officer
Sell
6,433
$4.95
$31.84K
Ozden Rabia Gurses
7 Jul 2023
Chief Medical Officer
Sell
832
$4.93
$4.10K
Mattessich Antony C.
6 Feb 2023
President and CEO
Sell
19,669
$4.24
$83.40K
Strassburger Philip C.
6 Feb 2023
General Counsel
Sell
6,181
$4.24
$26.21K
Notman Donald
6 Feb 2023
Chief Financial Officer
Sell
6,476
$4.24
$27.46K
Ozden Rabia Gurses
6 Feb 2023
Chief Medical Officer
Sell
6,416
$4.24
$27.20K
White Christopher G
6 Feb 2023
Chief Business Officer
Sell
5,829
$4.24
$24.71K
LINDSTROM RICHARD L MD
20 May 2021
Director
Sell
10,000
$14.30
$143.00K
Show all 140 transactions →

What was left out

Form 4 filings counted 258
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 46
Sales straight out of an exercise 1
Sales at will 24
Transactions with no price 1
Shares from compensation/vesting 12,632,639
Sales filed before the plan box existed 6
History held since 8 Nov 2016